Albania vs Malaysia: Access to anti-retroviral drugs, male
Albania
60.0%
in 2024
Malaysia
59.0%
in 2024
Albania rank
102nd
Malaysia rank
105th
Access to anti-retroviral drugs, male over time
- Albania
- Malaysia
How they compare
Albania currently reports 60.0% against 59.0% in Malaysia, a difference of 1.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Malaysia ahead.
Albania ranks 102nd and Malaysia ranks 105th of 141 countries.
Across the 3 decades both report, Albania averaged higher in 1 and Malaysia in 2.
Head to head by decade
| Decade | Albania | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 7.2% | 1.7% | Malaysia |
| 2010s | 36.1% | 29.7% | 6.4% | Albania |
| 2020s | 54.4% | 55.6% | 1.2% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Albania or Malaysia?
- Albania, at 60.0% against 59.0% in Malaysia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Albania and Malaysia?
- 1.0%, with Albania ahead.
- How many years of comparable data are there for Albania and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Albania and Malaysia rank globally for access to anti-retroviral drugs, male?
- Albania ranks 102nd and Malaysia ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.